Involvement of serine protease and proteinase-activated receptor 2 in dermatophyte-associated itch in mice

Keyphrases

• 2 Receptor 50%
• Arthroderma Vanbreuseghemii 62%
• Causal Mechanisms 12%
• Dermatophytes 100%
• FSLLRY-NH2 12%
• Heat Pretreatment 12%
• Hind Paw 12%
• Histamine H1 Receptor 12%
• Histamine Receptor Antagonist 12%
• Intradermal Injection 12%
• Itch 100%
• Mast Cell Activation Syndrome 12%
• N-terminal Peptide 12%
• N-terminus 12%
• Nafamostat Mesylate 12%
• Naloxone 12%
• Naltrexone 12%
• Opioid Antagonist 12%
• Protease-activated Receptor 2 (PAR2) 100%
• Proteolytic Cleavage 12%
• Receptor Antagonist 12%
• Serine Protease 100%
• Serine Protease Activity 12%
• Serine Protease Inhibitor 12%
• Serine Proteinase 100%
• Terfenadine 12%
• Tethered Ligands 12%
• Trypsin 12%
• Tryptase 12%

Medicine and Dentistry

• Amino Terminal Sequence 25%
• Dermatophyte 100%
• H1 Antagonist 12%
• Hind Paw 12%
• Intradermal Drug Administration 12%
• Mast Cell 12%
• Nafamstat Mesilate 12%
• Naloxone 12%
• Naltrexone 12%
• Opiate Antagonist 12%
• Proteinase 12%
• Proteinase Activated Receptor 2 100%
• Pruritus 100%
• Receptor 50%
• Receptor Antagonist 12%
• Serine Proteinase 100%
• Serine Proteinase Inhibitor 12%
• Terfenadine 12%
• Tryptase 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Dermatophyte 100%
• Histamine H1 Receptor Antagonist 12%
• Nafamstat Mesilate 12%
• Naloxone 12%
• Naltrexone 12%
• Narcotic Antagonist 12%
• Proteinase 12%
• Proteinase Activated Receptor 2 100%
• Pruritus 100%
• Receptor 50%
• Receptor Antagonist 12%
• Serine Proteinase 100%
• Serine Proteinase Inhibitor 12%
• Terfenadine 12%
• Trichophyton Interdigitale 62%
• Tryptase 12%